Rhone Ma Holdings Bhd
Rhone Ma Holdings Berhad, an investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia. The company provides diagnostic laboratory analysis and consultation services to veterinary, agriculture, and food industries; tests and diagnostics services for human healthcare; and veterinary advisory servic… Read more
Rhone Ma Holdings Bhd (5278) - Net Assets
Latest net assets as of September 2025: RM175.20 Million MYR
Based on the latest financial reports, Rhone Ma Holdings Bhd (5278) has net assets worth RM175.20 Million MYR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (RM245.74 Million) and total liabilities (RM70.54 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | RM175.20 Million |
| % of Total Assets | 71.29% |
| Annual Growth Rate | 13.88% |
| 5-Year Change | 44.39% |
| 10-Year Change | N/A |
| Growth Volatility | 20.35 |
Rhone Ma Holdings Bhd - Net Assets Trend (2015–2024)
This chart illustrates how Rhone Ma Holdings Bhd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Rhone Ma Holdings Bhd (2015–2024)
The table below shows the annual net assets of Rhone Ma Holdings Bhd from 2015 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | RM179.21 Million | +11.33% |
| 2023-12-31 | RM160.98 Million | +4.99% |
| 2022-12-31 | RM153.34 Million | +16.72% |
| 2021-12-31 | RM131.36 Million | +5.84% |
| 2020-12-31 | RM124.11 Million | +15.63% |
| 2019-12-31 | RM107.33 Million | +3.01% |
| 2018-12-31 | RM104.19 Million | +1.72% |
| 2017-12-31 | RM102.43 Million | +7.63% |
| 2016-12-31 | RM95.16 Million | +71.14% |
| 2015-12-31 | RM55.60 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Rhone Ma Holdings Bhd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 106.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | RM109.98 Million | 65.55% |
| Common Stock | RM117.27 Million | 69.90% |
| Total Equity | RM167.78 Million | 100.00% |
Rhone Ma Holdings Bhd Competitors by Market Cap
The table below lists competitors of Rhone Ma Holdings Bhd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Direct Finance TA
TA:DIFI
|
$4.26 Million |
|
Minaean SP Construction Corp
V:MSP
|
$4.26 Million |
|
PP PRIME Public Company Limited
BK:PPPM
|
$4.26 Million |
|
Forza Land Indonesia Tbk PT
JK:FORZ
|
$4.26 Million |
|
New Age Exploration Ltd
AU:NAE
|
$4.25 Million |
|
Lendway Inc.
NASDAQ:LDWY
|
$4.25 Million |
|
Mynaric AG
PINK:MOYFF
|
$4.25 Million |
|
Indo Acidatama Tbk
JK:SRSN
|
$4.25 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Rhone Ma Holdings Bhd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 160,979,350 to 167,782,000, a change of 6,802,650 (4.2%).
- Net income of 12,306,860 contributed positively to equity growth.
- Dividend payments of 5,530,650 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | RM12.31 Million | +7.34% |
| Dividends Paid | RM5.53 Million | -3.3% |
| Other Changes | RM26.44K | +0.02% |
| Total Change | RM- | 4.23% |
Book Value vs Market Value Analysis
This analysis compares Rhone Ma Holdings Bhd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.91x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.32x to 0.91x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | RM0.52 | RM0.69 | x |
| 2017-12-31 | RM0.56 | RM0.69 | x |
| 2018-12-31 | RM0.57 | RM0.69 | x |
| 2019-12-31 | RM0.59 | RM0.69 | x |
| 2020-12-31 | RM0.62 | RM0.69 | x |
| 2021-12-31 | RM0.65 | RM0.69 | x |
| 2022-12-31 | RM0.69 | RM0.69 | x |
| 2023-12-31 | RM0.73 | RM0.69 | x |
| 2024-12-31 | RM0.76 | RM0.69 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Rhone Ma Holdings Bhd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.34%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.82%
- • Asset Turnover: 0.94x
- • Equity Multiplier: 1.34x
- Recent ROE (7.34%) is below the historical average (10.01%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 21.64% | 11.41% | 1.26x | 1.50x | RM6.47 Million |
| 2016 | 9.63% | 7.69% | 0.99x | 1.26x | RM-350.48K |
| 2017 | 13.58% | 10.11% | 1.05x | 1.28x | RM3.66 Million |
| 2018 | 9.66% | 7.44% | 1.03x | 1.26x | RM-353.89K |
| 2019 | 8.05% | 7.25% | 0.80x | 1.39x | RM-2.10 Million |
| 2020 | 5.87% | 4.97% | 0.79x | 1.50x | RM-5.13 Million |
| 2021 | 8.58% | 6.65% | 0.87x | 1.49x | RM-1.87 Million |
| 2022 | 8.31% | 6.43% | 0.90x | 1.43x | RM-2.60 Million |
| 2023 | 7.50% | 5.95% | 0.88x | 1.43x | RM-4.02 Million |
| 2024 | 7.34% | 5.82% | 0.94x | 1.34x | RM-4.47 Million |
Industry Comparison
This section compares Rhone Ma Holdings Bhd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $165,924,708
- Average return on equity (ROE) among peers: 12.93%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Rhone Ma Holdings Bhd (5278) | RM175.20 Million | 21.64% | 0.40x | $4.26 Million |
| Kotra Industries Bhd (0002) | $65.03 Million | 15.36% | 0.20x | $23.04 Million |
| PeterLabs Holdings Bhd (0171) | $45.74 Million | 8.76% | 0.51x | $3.70 Million |
| Duopharma Biotech Bhd (7148) | $157.87 Million | 18.16% | 0.24x | $132.90 Million |
| YSP Southeast Asia Holding Bhd (7178) | $395.06 Million | 9.45% | 0.32x | $21.44 Million |